Borman Mark P

Avg. Two Year Performance

(89%) Avg. Purchase Return
(37%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return28%(11%)(76%)(58%)(89%)
Purchase Success Rate1 of 10 of 10 of 10 of 10 of 1
Average Sale Return----------
Sale Success Rate----------

Bioheart, Inc.

Drugs » Biotechnology

Director:

Holdings: 526.94K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--